PROVIDER PROFILE · NPI 1427399252
Claudia Moulden
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
67
Beneficiaries
—
Total drug cost
$6K
Distinct drugs
1
Brand share
100.0%
Top prescribed drugs
Progesterone, Micronized67 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Claudia Moulden's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 7 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| SOLSTAS LAB PARTNERS GROUP LLC | 132 | 293 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| THE PRESBYTERIAN HOSPITAL | 42 | 83 |
| SOLSTAS LAB PARTNERS GROUP LLC | 30 | 54 |
| Ahmad Kashif Al Ghita Rheumatology · Charlotte, NC | 18 | 30 |
| Andrew Laster Rheumatology · Charlotte, NC | 17 | 23 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Burlington, NC | 16 | 20 |
| KIPNIS, ROBERT | 11 | 18 |
| CAROLINAS MEDICAL CENTER | 11 | 14 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE